mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.049 |
0.4 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |